Search results for "Patients"

showing 10 items of 962 documents

Flupirtine protects both neuronal cells and lymphocytes against induced apoptosis in vitro: Implications for treatment of AIDS patients

1999

In the present study we demonstrate that flupirtine, an already clinically used, centrally acting, non-opiate analgesic agent, protects rat cortical neurons against HIV-gp120 induced apoptotic cell death. The drug was active at concentrations between 1 and 10 microg/ml. Furthermore we show inhibition of in vitro induced apoptosis in human blood mononuclear cells, using flupirtine. Induced apoptosis in peripheral blood mononuclear cells from healthy individuals and HIV-1 infected patients was reduced to approximately 50% after in vitro preincubation with flupirtine at concentrations between 0.1 and 10 microg/ml. The anti-apoptotic effect of flupirtine was restricted to CD3+ lymphocytes and i…

DrugAids patientsbiologybusiness.industryCD3media_common.quotation_subjectAnalgesicCell BiologyPharmacologyPeripheral blood mononuclear cellIn vitroApoptosisbiology.proteinMedicineFlupirtinebusinessMolecular Biologymedia_commonmedicine.drugCell Death & Differentiation
researchProduct

Determination of isoniazid and pyridoxine in plasma sample of tuberculosis patients by micellar liquid chromatography

2021

It is no doubt Isoniazid is a powerful tuberculosis drug, but it might give rise to Vitamin B6 (Pyridoxine) deficiency. In this case, a usual treatment is the combined administration of Isoniazid and Pyridoxine. An easy-to-conduct procedure based on Micellar Liquid Chromatography has been developed to quantify Isoniazid and Pyridoxine in plasma from Tuberculosis patients. The sample was diluted in mobile phase, filtered and directly injected, thus avoiding extraction or purification steps. Both drugs were adequately resolved from the matrix and endogenous compounds using a mobile phase made up of 0.15 M sodium dodecyl sulfate – 8%(v/v) 1-butanol – 0.01 M phosphate buffer at pH 3, running at…

DrugBioanalysismedia_common.quotation_subjectmicellar02 engineering and technology01 natural sciencespatientsAnalytical ChemistryMatrix (chemical analysis)chemistry.chemical_compoundmedicineantituberculosisSodium dodecyl sulfateSpectroscopyplasmamedia_commonChromatographyChemistry010401 analytical chemistryExtraction (chemistry)Isoniaziddrug021001 nanoscience & nanotechnologyPyridoxine0104 chemical sciencesMicellar liquid chromatography0210 nano-technologyoptimizationmedicine.drug
researchProduct

Lung deposition of extrafine inhaled corticosteroid (ICS)-containing fixed combinations drug in COPD patients using Functional Respiratory Imaging (F…

2018

Introduction: FRI is a novel computational fluid dynamics (CFD)-based technique using formulation profile and patients lung CT scan to simulate aerosol deposition. Aims and objectives: To evaluate lung deposition of pressurized metered dose inhaler (pMDI) extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium (BDP/FF/G Trimbow®) with pMDI extrafine BDP/FF (Foster®) pMDI and compared them with reference gamma scintigraphy data. Methods: FRI was used to assess, in silico, the deposition of pMDI combination products (BDP/FF/G and BDP/FF) in 20 moderate to severe COPD patients. FRI combined high-resolution lung CT scans of each patient with in silico computational flow simulati…

DrugInhalationLung depositionmedicine.diagnostic_testmedicine.drug_classCopd patientsbusiness.industrymedia_common.quotation_subjectBeclometasone dipropionaterespiratory systemScintigraphy030226 pharmacology & pharmacyMetered-dose inhaler03 medical and health sciences0302 clinical medicine030228 respiratory systemmedicineCorticosteroidNuclear medicinebusinessmedia_commonmedicine.drugAirway pharmacology and treatment
researchProduct

Zugangswege f�r die Medikamentenapplikation bei Herzkreislaufstillstand

1996

Selecting a route for drug administration during CPR requires consideration of the speed with which access can be obtained, the technical difficulties involved in performing the procedure, the associated risk of complications, delays in drug delivery to the central circulation, and the duration of effective drug levels following injection. The peripheral venous route is the safest method, and drug delivery can be enhanced by a fluid bolus after injection of the medication. The circulation time is shortest after central venous injection, but there is some risk of complications. The femoral route is associated with a high incidence of unsuccessful catherization. The endotracheal tube provides…

Drugmedicine.medical_specialtyAdult patientsbusiness.industrymedia_common.quotation_subjectDrug administrationGeneral Medicinelaw.inventionSurgeryRoute of administrationAnesthesiology and Pain MedicinelawAnesthesiaAnesthesiologyDrug deliveryCardiopulmonary bypassMedicinebusinessEndotracheal tubemedia_commonDer Anaesthesist
researchProduct

SP0027 Biosimilars: Potential Clinical Differences and European Regulatory Aspects

2014

Although successful drugs, the use of anti-TNFs is limited by their high cost, and in the present climate of economic difficulty, there is pressure to find alternatives that reproduce their effects at a lower price. Due to their large molecular size and structural complexity, anti-TNFs are impossible to duplicate, unlike smaller, chemically-generated compounds, which can be copied. However, unlike generics, biosimilars are similar rather than identical to the original drugs. Determining the level of similarity that guarantees a comparable efficacy and safety represents a new test for the pharmacological market. Biosimilars of smaller biological molecules, such as somatotropin, EPO and GCSF …

Drugmedicine.medical_specialtyProtein moleculesbusiness.industrymedia_common.quotation_subjectImmunologyBiosimilarPharmacologyGeneral Biochemistry Genetics and Molecular BiologyInfliximabClinical trialRheumatologyMolecular sizePharmacovigilancemedicineImmunology and AllergyIntensive care medicinebusinessPaediatric patientsmedicine.drugmedia_commonAnnals of the Rheumatic Diseases
researchProduct

Alternative to oral dicoumarin anticoagulants: Considerations in dental care

2013

Introduction: For over 50 years, vitamin K antagonists such as warfarin (Aldocumar®) and acenocoumarol (Sintrom®) have been the gold standard for reducing the risk of cerebrovascular events. In the last 5 years alternative anticoagulants have been evaluated that act directly upon a concrete target within the coagulation cascade, thereby affording a more predictable anticoagulant effect. The present study offers an update on the new oral anticoagulants and reviews the implications referred to the dental care of patients administered these substances. Material and methods: An exhaustive PubMed-Medline and Cochrane Library search was made of the main alternatives to conventional oral anticoagu…

Drugmedicine.medical_specialtyRivaroxabanAcenocoumarolbusiness.industrymedia_common.quotation_subjectGold standardWarfarinReviewCochrane LibraryDabigatranMedicineOdontostomatology for the Disabled or Special PatientsApixabanbusinessIntensive care medicineGeneral Dentistrymedicine.drugmedia_commonJournal of Clinical and Experimental Dentistry
researchProduct

797 Infliximab in the Treatment of Pediatric Ibd: A Single Centre Experience

2010

Background and aims: The biological treatment of IBD acts on different stages of immunophysiopathological processes of the disease. We describe evolution and clinical response to Infliximab in paediatric patients affected by IBD diagnosed and followed at our centre. Methods: In the last triennial period at our Department of Paediatrics in Palermo 53 infusions of Infliximab were administrated to our patients affected by severe forms of IBD. All patients but one were affected by several forms of CD. Only one child was affected by U.C. associated to pyoderma gangrenosum. The total number of infusions were administrated according the ACCENT 1 study at a dose of 5 mg/Kg. All the infusions were p…

Drugmedicine.medical_specialtybusiness.industrymedia_common.quotation_subjectDiseasemedicine.diseaseInfliximabDiscontinuationSingle centreTolerabilityInternal medicinePediatrics Perinatology and Child HealthmedicinebusinessPyoderma gangrenosummedia_commonPaediatric patientsmedicine.drugPediatric Research
researchProduct

The role of prognostic stratification on prescription of anticoagulants in older patients with atrial fibrillation : a multicenter, observational, pr…

2022

Background: Literature suggests that different risks of mortality could influence physicians in prescribing or not anticoagulants in older patients with atrial fibrillation (AF). The Multidimensional Prognostic Index (MPI) can be considered a tool for the detection of multidimensional frailty. The aim of this cross-sectional study was to evaluate whether prescription patterns of oral anticoagulants exist, based on MPI values. Methods: Older hospitalised patients (age >= 65 years) with non-valvular AF were included across 24 European centres. MPI was calculated using validated and standardised tools derived from a comprehensive geriatric assessment. Other functional and clinical information …

EUROSAF; anticoagulants; comprehensive geriatric assessment; frailty; multidimensional prognostic index; older peopleanticoagulantsAdministration OralfrailtyVALIDATIONolder peopleRisk FactorsAtrial FibrillationEUROSAFHumansProspective StudiesELDERLY-PATIENTSINDEXAgedAged 80 and overMORTALITYGeneral MedicineADULTScomprehensive geriatric assessmentPrognosismultidimensional prognostic indexCross-Sectional StudiesPrescriptions3121 General medicine internal medicine and other clinical medicineFemaleEUROSAF anticoagulants comprehensive geriatric assessment frailty multidimensional prognostic index older peopleSTROKE
researchProduct

Market empowerment of the patient: the French experience.

2011

Through analysis of the French experience, this article explores the way economic policy has sought to encourage active, well-informed patients by giving them market power. The new status of the patient as consumer is based on two foundations: the endeavour to build a healthcare market and the activation of demand-based policies. The keystone of this new system is a conception of the market as a process constructed by economic policy. Recent measures such as the standardization of care and the introduction of incentives to respect a treatment pathway then constitute effective levers to establish a free-market rationale.

Economics and EconometricsStandardizationCompulsory insurancePatientsEconomicsmedia_common.quotation_subjectCopaymentsHealth Care SectorHistory 21st Century03 medical and health sciencesNational health insurance0302 clinical medicineHealth insurance0502 economics and businessHealth careEconomics[ SHS.ECO ] Humanities and Social Sciences/Economies and finances030212 general & internal medicineConsumer economicsMarket power050207 economicsEmpowerment[SHS.ECO] Humanities and Social Sciences/Economics and FinanceComputingMilieux_MISCELLANEOUSmedia_commonConsumer economicsPublic economics[QFIN]Quantitative Finance [q-fin]Consumer Health Informationbusiness.industry05 social sciencesPersonal empowermentNonmarket forcesStandard of CareHistory 20th Century[SHS.ECO]Humanities and Social Sciences/Economics and Finance[QFIN] Quantitative Finance [q-fin]ReimbursementIncentiveInsurance providersMarket PowerPatient RightsFranceMarketizationPower PsychologicalbusinessReview of social economy
researchProduct

Use of Eribulin mesylate as second-line therapy in elderly patients with HER/2 negative metastatic breast cancer (MBC): Efficacy, tolerability and Qu…

2020

OBJECTIVE: Eribulin mesylate (Halaven®) is a non-taxane inhibitor of microtubule indicated as monotherapy in patients with metastatic breast cancer (MBC), which progresses after anthracycline and taxanes therapy. In this retrospective observational study, we want to evaluate the efficacy of Eribulin in elderly women with MBC pretreated with anthracyclines and taxanes. PATIENTS AND METHODS: 40 elderly patients > 70 years of age were enrolled, and the median age was 76 years (range 70-82). Overall survival (OS), Progression Free Survival (PFS), Objective Response Rate (ORR) were primary endpoints, tolerability, carcinoembryonic antigen levels 15.3 (Ca 15.3), before and after treatment, and…

Elderly patientsHalavenCa 15.3Quality of life]SurvivalMetastatic breast cancer
researchProduct